I
Inquis Medical
Thrombectomy system for removing blood clots in venous thromboembolism
About Inquis Medical
Inquis Medical is a Menlo Park, California-based commercial-stage medical device company that develops technologies for treating venous thromboembolism (VTE), including pulmonary embolism (PE) and clots in the peripheral veins. It was founded in 2020 by Vahid Saadat and Mojgan Saadat, who lead the company as co-CEOs.
Its product, the AVENTUS Thrombectomy System, removes blood clots from vessels without surgery. The system combines TrueClot tissue sensing, which gives physicians real-time feedback on whether the catheter tip is touching blood, clot or vessel wall; directional aspiration, including a catheter that can be rotated 360 degrees towards the clot; an integrated dilator and navigation catheter; and in-line filtering that returns the patient's own blood during the procedure to limit blood loss. AVENTUS received FDA 510(k) clearance for peripheral use in 2023, was cleared for treating pulmonary embolism in June 2025 after a 120-patient pivotal trial, and has since been expanded with a new catheter and introducer sheath.
Inquis sells AVENTUS to hospitals in the United States for use by interventional physicians, following its US commercial launch.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 80
- Open positions
- None listed
- Dealroom signal
- 93.5/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Surgery, Cardiology and cardiovascular, Catheters, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
| Role | Team | Location | Posted |
|---|---|---|---|
| Sr. Director of OperationsOperations | Operations | Menlo Park, CA | 1mo ago |
| Group Manager, Strategic MarketingMarketing | Marketing | Menlo Park, CA | 2mo ago |
| District Sales Manager - AtlantaSales | Sales | Atlanta, GA | 2mo ago |
| District Sales Manager - HoustonSales | Sales | Houston, TX | 2mo ago |
| District Sales Manager - Las VegasSales | Sales | Las Vegas, NV | 2mo ago |
| District Sales Manager - ChicagoSales | Sales | Chicago, IL | 2mo ago |
| District Sales Manager - New OrleansSales | Sales | New Orleans, LA | 2mo ago |
| District Sales Manager - KnoxvilleSales | Sales | Knoxville, TN | 3mo ago |
| Marketing & Communications ManagerMarketing | Marketing | Menlo Park, CA | 3mo ago |
| Principal R&D EngineerEngineering | Engineering | Menlo Park, CA | 3mo ago |
| District Sales Manager - JacksonvilleSales | Sales | Jacksonville, FL | 3mo ago |
| District Sales Manager - SeattleSales | Sales | Seattle, WA | 3mo ago |
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Jan 2026 | $75M | $300M | Undisclosed | ↗ |
| SERIES BOther financing | Nov 2024 | $40M | $160M | ShangBay Capital · Yu Galaxy · ENDpoint Ventures · Marshall Wace | ↗ |
Growth signals
Latest recorded traffic for Inquis Medical is 1.9K monthly website visits, down 20.8% over the last three months. Inquis Medical's team grew 40.4% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Inquis Medical in the Menlo Park ecosystem
The Inquis Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
- SVSynergy Ventures
Series A4 investors entered at this stage
Marshall Wace
ShangBay Capital
Yu Galaxy
ENDpoint Ventures
Source: Dealroom Talent Intelligence.
See Inquis Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








